-
-
-
-
-
-
-
Leerink Starts Viatris (VTRS) at Outperform
-
-
-
-
-
-
-
FDA accepts Viatris drug application for fast-acting meloxicam pain treatment
-
-
-
-
-
-
-
Increasing unusual option volume: WOOF HIMX SKM BMBL VTRS
-
-
-
-
-
-
-
Viatris (VTRS) PT Raised to $12 at Piper Sandler
-
-
-
-
-
-
-
Truist Securities Starts Viatris (VTRS) at Buy
-
-
-
-
-
-
-
Viatris Inc (VTRS) Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141
-
-
-
-
-
-
-
VTRS CLASS ALERT: Viatris Inc. Investors with Losses are Notified to Contact BFA Law before Tuesday's June 3 Securities Fraud Class Action Deadline
-
479,048 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


